Ophthalmology

Biography

Avinoam Ophir completed his medical studies and Residency in Hadassah Medical Center in Israel. During his Retina fellowship in Bascom Palmer Eye Institute, he together with another young doctor, Mark Blumenkranz, introduced the antimetabolites, primarily 5-FU, to the ophthalmology world, in order to treat non-malignant proliferating cells, especially in the prevention of postoperative scarring. Due to 5-FU efficacy in trabeculectomy, Dr. Ophir moved to specialize also in glaucoma. He explained the mechanism of MMC on bleb toxicity and how to prevent it, and also introduced the "mini-trabeculectomy" approach without radial incisions. Meanwhile he and his team found that Zn-Desferal in the cat substantially inhibited reperfusion injury following CRAO. He was appointed as chairman in the department of Ophthalmology in Hadera in 1993, associated with the Technion School of Medicine. For the last 4 years he works at the retina unit in Wolfson MC

Research Interest

Retina and Glaucoma